Search Results - "Dayimu, Alimu"

Sample size determination via learning-type curves

Dayimu, Alimu, Simidjievski, Nikola, Demiris, Nikolaos, Abraham, Jean

A comprehensive evaluation on the associations between hearing and vision impairments and risk of all-cause and cause-specific dementia: results from cohort study, meta-analysis and Mendelian randomization study

Jiang, Fan^{Aff1, Aff2}, Dong, Qiuyue, Wu, Sijia, Liu, Xinhui, Dayimu, Alimu, Liu, Yingying, Ji, Hanbing, Wang, Le, Liu, Tiemei, Li, Na, Li, Xiaofei, Fu, Peipei^{Aff2, Aff6}, Jing, Qi^{Aff7, Aff8}, Zhou, Chengchao, Li, Hongkai^{Aff3, IDs12916024037487_cor15}, Xu, Lei^{Aff1, IDs12916024037487_cor16}, Chen, Shanquan^{Aff9, IDs12916024037487_cor17}, Wang, Haibo^{Aff1, IDs12916024037487_cor18}

The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer

Abraham, Jean E.^{Aff1, Aff2, IDs41586024073842_cor1}, Pinilla, Karen^{Aff1, Aff2}, Dayimu, Alimu, Grybowicz, Louise, Demiris, Nikolaos, Harvey, Caron, Drewett, Lynsey M., Lucey, Rebecca^{Aff1, Aff2}, Fulton, Alexander^{Aff1, Aff2}, Roberts, Anne N., Worley, Joanna R.^{Aff1, Aff2}, Chhabra, Anita, Qian, Wendi, Vallier, Anne-Laure, Hardy, Richard M., Chan, Steve, Hickish, Tamas, Tripathi, Devashish^{Aff11, Aff12}, Venkitaraman, Ramachandran, Persic, Mojca, Aslam, Shahzeena, Glassman, Daniel, Raj, Sanjay^{Aff17, Aff18, Aff19}, Borley, Annabel, Braybrooke, Jeremy P., Sutherland, Stephanie, Staples, Emma, Scott, Lucy C., Davies, Mark, Palmer, Cheryl A., Moody, Margaret, Churn, Mark J.^{Aff28, Aff29, Aff30}, Newby, Jacqueline C., Mukesh, Mukesh B., Chakrabarti, Amitabha, Roylance, Rebecca R., Schouten, Philip C., Levitt, Nicola C., McAdam, Karen, Armstrong, Anne C., Copson, Ellen R., McMurtry, Emma, Tischkowitz, Marc, Provenzano, Elena, Earl, Helena M.^{Aff1, Aff2}

Global evolving patterns and cross-country inequalities of inflammatory bowel disease burden from 1990 to 2019: a worldwide report

Cao, Lina, Dayimu, Alimu, Guan, Xiao, Duan, Miao, Zeng, Shuyan^{Aff3, Aff4}, Wang, Hui^{Aff3, Aff4}, Zong, Jiahao^{Aff3, Aff4}, Sun, Chunhua, Yang, Xiaorong^{Aff3, Aff4, Aff5, IDs00011023018367_cor9}, Yang, Xiaoyun^{Aff3, Aff4, Aff5, IDs00011023018367_cor10}

Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial

Abraham, Jean E.^{Aff1, Aff2, IDs41467025591510_cor1}, O’Connor, Lenka Oplustil, Grybowicz, Louise, Alba, Karen Pinilla^{Aff1, Aff2}, Dayimu, Alimu, Demiris, Nikolaos, Harvey, Caron, Drewett, Lynsey M., Lucey, Rebecca^{Aff1, Aff2}, Fulton, Alexander^{Aff1, Aff2}, Roberts, Anne N., Worley, Joanna R.^{Aff1, Aff2}, Chhabra, Ms Anita, Qian, Wendi, Brown, Jessica, Hardy, Richard, Vallier, Anne-Laure, Chan, Steve^{Aff10, Aff11}, Cidon, Maria Esther Una, Sherwin, Elizabeth, Chakrabarti, Amitabha, Sadler, Claire, Barnes, Jen, Persic, Mojca, Smith, Sarah, Raj, Sanjay^{Aff18, Aff19}, Borley, Annabel, Braybrooke, Jeremy P., Staples, Emma, Scott, Lucy C., Palmer, Cheryl A., Moody, Margaret, Churn, Mark J., Pilger, Domenic, Zagnoli-Vieira, Guido, Wijnhoven, Paul W. G., Mukesh, Mukesh B., Roylance, Rebecca R., Schouten, Philip C., Levitt, Nicola C., McAdam, Karen, Armstrong, Anne C., Copson, Ellen R., McMurtry, Emma, Galbraith, Susan, Tischkowitz, Marc, Provenzano, Elena, O’Connor, Mark J., Earl, Helena M.

A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAFV600 mutant advanced melanoma (INTERIM)

Dayimu, Alimu, Gupta, Avinash, Matin, Rubeta N., Nobes, Jenny, Board, Ruth, Payne, Miranda, Rao, Ankit, Fusi, Alberto, Danson, Sarah, Eccles, Bryony, Carser, Judith, Brown, Ciara O’Hanlon, Steven, Neil, Bhattacharyya, Madhumita, Brown, Ewan, Gonzalez, Michael, Highley, Martin, Pickering, Lisa, Kumar, Satish, Waterston, Ashita, Burghel, George, Demain, Leigh, Baker, Eleanor, Wulff, Jerome, Qian, Wendi, Twelves, Sophie, Middleton, Mark, Corrie, Pippa

Clinical and biological markers predictive of treatment response associated with metastatic pancreatic adenocarcinoma

Dayimu, Alimu, Di Lisio, Lorena, Anand, Shubha, Roca-Carreras, Isart, Qian, Wendi, Al-Mohammad, Abdulrahman, Basu, Bristi, Valle, Juan W., Jodrell, Duncan, Demiris, Nikos^{Aff3, Aff7}, Corrie, Pippa^{Aff4, IDs41416023021709_cor11}

Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma

Mehta, Ishan, Dayimu, Alimu, Kumar, Satish, Boobier, Clare, Oladipo, Olabode, Burke, David, Olson-Brown, Anna, Yesildag, Pembe, Nobes, Jenny, Brown, Stephanie, Booth, Catherine, Wheater, Matthew, Muller, Daniel, Fountain, Vanessa, Ford, Lucy, Board, Ruth, McGurk, Luke, Twelves, Sophie, Demiris, Nikos, Corrie, Pippa

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Trajectories of Haemoglobin and incident stroke risk: a longitudinal cohort study

Dayimu, Alimu, Qian, Wendi, Fan, Bingbing, Wang, Chunxia, Li, Jiangbing, Wang, Shukang, Ji, Xiaokang, Zhou, Guangshuai, Zhang, Tao^Aff1, Xue, Fuzhong^Aff1

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.